nodes	percent_of_prediction	percent_of_DWPC	metapath
Carmustine—CYP1A2—Thalidomide—leprosy	0.369	0.508	CbGbCtD
Carmustine—CYP1A2—Rifampicin—leprosy	0.357	0.492	CbGbCtD
Carmustine—Teratogenicity—Thalidomide—leprosy	0.015	0.0548	CcSEcCtD
Carmustine—Disease progression—Thalidomide—leprosy	0.0144	0.0526	CcSEcCtD
Carmustine—Acute leukaemia—Thalidomide—leprosy	0.011	0.0402	CcSEcCtD
Carmustine—Skin necrosis—Thalidomide—leprosy	0.00899	0.0329	CcSEcCtD
Carmustine—Meningitis—Thalidomide—leprosy	0.0081	0.0296	CcSEcCtD
Carmustine—Grand mal convulsion—Thalidomide—leprosy	0.0066	0.0241	CcSEcCtD
Carmustine—Skin exfoliation—Dapsone—leprosy	0.00586	0.0214	CcSEcCtD
Carmustine—Febrile neutropenia—Thalidomide—leprosy	0.00522	0.0191	CcSEcCtD
Carmustine—Myasthenia—Thalidomide—leprosy	0.005	0.0183	CcSEcCtD
Carmustine—Oral candidiasis—Thalidomide—leprosy	0.00494	0.0181	CcSEcCtD
Carmustine—Burning sensation—Thalidomide—leprosy	0.00452	0.0165	CcSEcCtD
Carmustine—Interstitial lung disease—Thalidomide—leprosy	0.00444	0.0162	CcSEcCtD
Carmustine—Thrombosis—Thalidomide—leprosy	0.00444	0.0162	CcSEcCtD
Carmustine—Stupor—Thalidomide—leprosy	0.00421	0.0154	CcSEcCtD
Carmustine—Muscular weakness—Dapsone—leprosy	0.00393	0.0144	CcSEcCtD
Carmustine—Accidental injury—Thalidomide—leprosy	0.00355	0.013	CcSEcCtD
Carmustine—Thinking abnormal—Thalidomide—leprosy	0.00343	0.0125	CcSEcCtD
Carmustine—Drug interaction—Thalidomide—leprosy	0.00339	0.0124	CcSEcCtD
Carmustine—Neuropathy peripheral—Dapsone—leprosy	0.00336	0.0123	CcSEcCtD
Carmustine—Leukocytosis—Thalidomide—leprosy	0.00334	0.0122	CcSEcCtD
Carmustine—Gait disturbance—Thalidomide—leprosy	0.00322	0.0118	CcSEcCtD
Carmustine—Coordination abnormal—Thalidomide—leprosy	0.0032	0.0117	CcSEcCtD
Carmustine—Neck pain—Thalidomide—leprosy	0.00318	0.0116	CcSEcCtD
Carmustine—Pulmonary embolism—Thalidomide—leprosy	0.00314	0.0115	CcSEcCtD
Carmustine—Depressed level of consciousness—Thalidomide—leprosy	0.00303	0.0111	CcSEcCtD
Carmustine—Skin exfoliation—Thalidomide—leprosy	0.003	0.011	CcSEcCtD
Carmustine—Candida infection—Thalidomide—leprosy	0.003	0.011	CcSEcCtD
Carmustine—Neuropathy—Thalidomide—leprosy	0.00295	0.0108	CcSEcCtD
Carmustine—Gynaecomastia—Thalidomide—leprosy	0.00281	0.0103	CcSEcCtD
Carmustine—Mental disability—Thalidomide—leprosy	0.00273	0.00996	CcSEcCtD
Carmustine—Sepsis—Thalidomide—leprosy	0.00273	0.00996	CcSEcCtD
Carmustine—Erythema—Dapsone—leprosy	0.00268	0.00981	CcSEcCtD
Carmustine—Thrombophlebitis—Thalidomide—leprosy	0.00263	0.00963	CcSEcCtD
Carmustine—Diabetes mellitus—Thalidomide—leprosy	0.00262	0.00958	CcSEcCtD
Carmustine—Vision blurred—Dapsone—leprosy	0.00253	0.00924	CcSEcCtD
Carmustine—Eye pain—Thalidomide—leprosy	0.00253	0.00923	CcSEcCtD
Carmustine—Injury—Thalidomide—leprosy	0.00248	0.00907	CcSEcCtD
Carmustine—Amnesia—Thalidomide—leprosy	0.00243	0.00887	CcSEcCtD
Carmustine—Hyponatraemia—Thalidomide—leprosy	0.00229	0.00837	CcSEcCtD
Carmustine—Gastrointestinal haemorrhage—Thalidomide—leprosy	0.00228	0.00834	CcSEcCtD
Carmustine—Diplopia—Thalidomide—leprosy	0.00228	0.00834	CcSEcCtD
Carmustine—Face oedema—Thalidomide—leprosy	0.0022	0.00805	CcSEcCtD
Carmustine—Ataxia—Thalidomide—leprosy	0.00214	0.00784	CcSEcCtD
Carmustine—Tachycardia—Dapsone—leprosy	0.00214	0.00781	CcSEcCtD
Carmustine—Liver function test abnormal—Thalidomide—leprosy	0.0021	0.0077	CcSEcCtD
Carmustine—Hypokalaemia—Thalidomide—leprosy	0.00207	0.00759	CcSEcCtD
Carmustine—Muscular weakness—Thalidomide—leprosy	0.00201	0.00735	CcSEcCtD
Carmustine—Insomnia—Dapsone—leprosy	0.00198	0.00724	CcSEcCtD
Carmustine—Dysphagia—Thalidomide—leprosy	0.00197	0.0072	CcSEcCtD
Carmustine—Pancytopenia—Thalidomide—leprosy	0.00187	0.00684	CcSEcCtD
Carmustine—Neutropenia—Thalidomide—leprosy	0.00184	0.00674	CcSEcCtD
Carmustine—Gastrointestinal pain—Dapsone—leprosy	0.00179	0.00654	CcSEcCtD
Carmustine—Hyperglycaemia—Thalidomide—leprosy	0.00178	0.0065	CcSEcCtD
Carmustine—Pneumonia—Thalidomide—leprosy	0.00177	0.00646	CcSEcCtD
Carmustine—Depression—Thalidomide—leprosy	0.00175	0.0064	CcSEcCtD
Carmustine—Abdominal pain—Dapsone—leprosy	0.00173	0.00633	CcSEcCtD
Carmustine—Body temperature increased—Dapsone—leprosy	0.00173	0.00633	CcSEcCtD
Carmustine—Renal failure—Thalidomide—leprosy	0.00173	0.00631	CcSEcCtD
Carmustine—Neuropathy peripheral—Thalidomide—leprosy	0.00172	0.0063	CcSEcCtD
Carmustine—Stomatitis—Thalidomide—leprosy	0.00171	0.00626	CcSEcCtD
Carmustine—Hypoaesthesia—Thalidomide—leprosy	0.00157	0.00574	CcSEcCtD
Carmustine—Oedema peripheral—Thalidomide—leprosy	0.00155	0.00568	CcSEcCtD
Carmustine—Visual impairment—Thalidomide—leprosy	0.00152	0.00556	CcSEcCtD
Carmustine—Eye disorder—Thalidomide—leprosy	0.00147	0.00539	CcSEcCtD
Carmustine—Arrhythmia—Thalidomide—leprosy	0.00141	0.00515	CcSEcCtD
Carmustine—Alopecia—Thalidomide—leprosy	0.00139	0.0051	CcSEcCtD
Carmustine—Vomiting—Dapsone—leprosy	0.00139	0.00509	CcSEcCtD
Carmustine—Mental disorder—Thalidomide—leprosy	0.00138	0.00505	CcSEcCtD
Carmustine—Malnutrition—Thalidomide—leprosy	0.00137	0.00502	CcSEcCtD
Carmustine—Headache—Dapsone—leprosy	0.00137	0.00501	CcSEcCtD
Carmustine—Back pain—Thalidomide—leprosy	0.00133	0.00486	CcSEcCtD
Carmustine—Nausea—Dapsone—leprosy	0.0013	0.00475	CcSEcCtD
Carmustine—Vision blurred—Thalidomide—leprosy	0.00129	0.00473	CcSEcCtD
Carmustine—Tremor—Thalidomide—leprosy	0.00129	0.0047	CcSEcCtD
Carmustine—Anaemia—Thalidomide—leprosy	0.00127	0.00464	CcSEcCtD
Carmustine—Agitation—Thalidomide—leprosy	0.00126	0.00461	CcSEcCtD
Carmustine—Leukopenia—Thalidomide—leprosy	0.00123	0.00449	CcSEcCtD
Carmustine—Convulsion—Thalidomide—leprosy	0.00119	0.00435	CcSEcCtD
Carmustine—Hypertension—Thalidomide—leprosy	0.00119	0.00433	CcSEcCtD
Carmustine—Chest pain—Thalidomide—leprosy	0.00117	0.00427	CcSEcCtD
Carmustine—Myalgia—Thalidomide—leprosy	0.00117	0.00427	CcSEcCtD
Carmustine—Anxiety—Thalidomide—leprosy	0.00116	0.00426	CcSEcCtD
Carmustine—Confusional state—Thalidomide—leprosy	0.00113	0.00413	CcSEcCtD
Carmustine—Oedema—Thalidomide—leprosy	0.00112	0.0041	CcSEcCtD
Carmustine—Infection—Thalidomide—leprosy	0.00111	0.00407	CcSEcCtD
Carmustine—Thrombocytopenia—Thalidomide—leprosy	0.0011	0.00401	CcSEcCtD
Carmustine—Tachycardia—Thalidomide—leprosy	0.00109	0.004	CcSEcCtD
Carmustine—Anorexia—Thalidomide—leprosy	0.00107	0.0039	CcSEcCtD
Carmustine—Hypotension—Thalidomide—leprosy	0.00105	0.00383	CcSEcCtD
Carmustine—Musculoskeletal discomfort—Thalidomide—leprosy	0.00102	0.00373	CcSEcCtD
Carmustine—Insomnia—Thalidomide—leprosy	0.00101	0.00371	CcSEcCtD
Carmustine—Paraesthesia—Thalidomide—leprosy	0.00101	0.00368	CcSEcCtD
Carmustine—Dyspnoea—Thalidomide—leprosy	0.000999	0.00365	CcSEcCtD
Carmustine—Somnolence—Thalidomide—leprosy	0.000996	0.00364	CcSEcCtD
Carmustine—Decreased appetite—Thalidomide—leprosy	0.000974	0.00356	CcSEcCtD
Carmustine—Gastrointestinal disorder—Thalidomide—leprosy	0.000967	0.00354	CcSEcCtD
Carmustine—Constipation—Thalidomide—leprosy	0.000958	0.0035	CcSEcCtD
Carmustine—Pain—Thalidomide—leprosy	0.000958	0.0035	CcSEcCtD
Carmustine—Feeling abnormal—Thalidomide—leprosy	0.000923	0.00338	CcSEcCtD
Carmustine—Gastrointestinal pain—Thalidomide—leprosy	0.000916	0.00335	CcSEcCtD
Carmustine—Abdominal pain—Thalidomide—leprosy	0.000886	0.00324	CcSEcCtD
Carmustine—Body temperature increased—Thalidomide—leprosy	0.000886	0.00324	CcSEcCtD
Carmustine—Hypersensitivity—Thalidomide—leprosy	0.000825	0.00302	CcSEcCtD
Carmustine—Asthenia—Thalidomide—leprosy	0.000804	0.00294	CcSEcCtD
Carmustine—Diarrhoea—Thalidomide—leprosy	0.000767	0.0028	CcSEcCtD
Carmustine—Dizziness—Thalidomide—leprosy	0.000741	0.00271	CcSEcCtD
Carmustine—Vomiting—Thalidomide—leprosy	0.000712	0.0026	CcSEcCtD
Carmustine—Rash—Thalidomide—leprosy	0.000706	0.00258	CcSEcCtD
Carmustine—Dermatitis—Thalidomide—leprosy	0.000706	0.00258	CcSEcCtD
Carmustine—Headache—Thalidomide—leprosy	0.000702	0.00257	CcSEcCtD
Carmustine—Nausea—Thalidomide—leprosy	0.000666	0.00243	CcSEcCtD
